A Community Collaboration Between IU Health and St. Vincent
Current Studies & Research
The interFACE Lab

The interFACE Lab The Interactive and Functional Assessment of Communication and Emotion (InterFACE) Center is a natural observation laboratory designed to research emotional and behavioral deficits in people with neurological,… Read More

TrackTBI

TrackTBI Investigator: Richard Rodgers, MD TRACK-TBI:  The multicenter Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study aims to improve success of clinical trial design through the collection and analysis of… Read More

Training to Reconnect with emotional awareness therapy

Training to Reconnect with emotional awareness therapy (TREAT) Investigators: Dawn Neumann, Flora Hammond The purpose of this study is to teach participants with traumatic brain injury to develop better emotional… Read More

Avanir Study

Avanir Study Sheryl Katta-Charles MD, Principal Investigator A Phase 2, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability or AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for… Read More

Monitoring Safety and Training in Patients with Spinal Cord Injuries

Long-Term, Prospective, Non-Interventional Study Monitoring Safety and Training in Patients with Spinal Cord Injuries and Their Trained Companions Recently Initiated with the ReWalk™ Personal Device. Flora Hammond, MD (PI), funded… Read More

SEE ALL RESEARCH
BACK
Training to Reconnect with emotional awareness therapy August 13th, 2018

Training to Reconnect with emotional awareness therapy (TREAT)

Investigators: Dawn Neumann, Flora Hammond

The purpose of this study is to teach participants with traumatic brain injury to develop better emotional self-awareness and ability to describe and communicate their emotions. Participants who consent and qualify for the study will be randomized to immediately receive treatment or a waitlist control. The treatment is eight 60-90 minute sessions one-on-one with a clinician that will take place twice a week for one month. All subjects will eventually receive treatment. Changes in emotional awareness, emotion regulation, anxiety, depression, anger, and affect will be measured at the end of treatment and a 3 months follow-up. Caregivers will also be asked to report on perceived changes. Patient satisfaction will also be evaluated.

Contact:   The InterFACE Center

Email: interfac@iupui.edu

Phone: (317) 329-2380